Delivery Order SPE2DB22D1202-SPE2DB25FVGN5
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) for Ozempic 0.25–0.5 mg/dose pens (3 mL) valued at $7,440.06. Awarded on July 28, 2025, with a firm fixed price structure and ultimate completion date of July 29, 2025, this competitively awarded contract includes no set-aside designation. The place of performance is located at the contractor's corporate office in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL). The contract, valued at $7,888.63, is structured as a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. Performance will be completed at the vendor's Conshohocken facility by the ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 20, 2025, valued at $9,486.77. The contract calls for the delivery of Ozempic 0.25–0.5 mg/dose pens (3 mL) to support federal medical supply requirements. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for ultimate completion by August 21, 2025, with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 18, 2025, for Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $1,253.32. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $10,069.95 for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml). The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, carries a firm fixed price structure and was not designated as a set-aside award. Performance will be executed at AmerisourceBergen's corporate office location...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, with a ceiling value of $15,364.62 for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL). The contract employs firm fixed pricing with no set-aside designation, indicating a competitive award. The place of performance is listed as Conshohocken, Pennsylvania, and the ultimate completion date is August...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $9,153.24. This competitively awarded, firm fixed-price contract represents a single delivery order with an ultimate completion date of August 22, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $28,322.36 and an ultimate completion date of July 22, 2025. The contract carries no set-aside designation, indicating it was competed among qualified vendors through open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The delivery order, valued at $33,789.66, represents a firm fixed price contract with an ultimate completion date of September 19, 2025, and was competitively awarded with no set-aside designation. Performance will occur at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) pre-filled pens with a ceiling value of $3,519.05. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...